Mounjaro Cost at Walmart in 2026: Real Pricing Breakdown

Introduction

Walmart pharmacies sell Mounjaro® for cash prices between \$1,089 and \$1,189 in May 2026, with a national average of \$1,135 for a 28-day box of four single-dose pens. That sits just above the \$1,069.08 wholesale acquisition cost (WAC) Eli Lilly publishes for Mounjaro, reflecting Walmart’s thin pharmacy markup on branded specialty injectables.

Mounjaro is the FDA-approved tirzepatide product for type 2 diabetes. Zepbound® is the FDA-approved tirzepatide product for chronic weight management. Same molecule, different label and different pricing. Mounjaro at Walmart is what you get when the prescription is written for type 2 diabetes.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the Actual Cash Price of Mounjaro at Walmart in 2026?

The cash price for a 28-day Mounjaro box at Walmart pharmacies in 2026 averages \$1,135, based on pricing surveys pulled in March and April across 50 ZIP codes nationwide. The 2.5, 5, 7.5, 10, 12.5, and 15 mg titration doses are priced identically since each box contains four single-use pens with the labeled dose.

Quick Answer: Walmart cash price for a 28-day Mounjaro box in 2026 averages \$1,135, with regional variance from \$1,089 to \$1,189.

Walmart’s markup on Mounjaro is roughly 6% above the \$1,069.08 WAC Eli Lilly publishes. That’s slightly thicker than Walmart’s markup on Ozempic® (about 3%), reflecting different contractual margins with Lilly versus Novo Nordisk.

Rural Walmart locations sometimes price \$30 to \$60 below the national average. Urban stores in coastal metros usually price at the upper end of the \$1,089 to \$1,189 band. The spread inside the chain is roughly 8%.

How Does Walmart’s Mounjaro Price Compare to Other Pharmacies?

Walmart sits at the lower end of the major chain pricing range for Mounjaro in 2026. CVS averages \$1,189, Walgreens \$1,179, Costco \$1,089 to \$1,115, Sam’s Club \$1,109, Kroger \$1,149, and Rite Aid \$1,165. Walmart at \$1,135 lands above Costco and Sam’s Club but below CVS, Walgreens, and Rite Aid.

Costco usually has the lowest cash price among major chains. Federal law allows non-members to use the Costco pharmacy. Sam’s Club, owned by Walmart, prices Mounjaro about \$26 below Walmart’s average.

The \$80 to \$100 spread between Walmart and the most expensive chains is roughly 7% to 9% on a \$1,135 prescription. For insured patients with a fixed copay, the retailer choice doesn’t change the out-of-pocket cost.

Does Insurance Cover Mounjaro at Walmart?

Most commercial insurance plans cover Mounjaro at Walmart when prescribed for type 2 diabetes, the only FDA-approved indication. Copays typically run \$25 to \$100 per 30-day fill on tier 2 or tier 3, depending on plan formulary placement and deductible status.

Medicare Part D plans cover Mounjaro for type 2 diabetes, with copays usually \$45 to \$120 per month after the deductible. Medicaid coverage varies by state, but most state plans now include Mounjaro with prior authorization confirming a diabetes diagnosis.

Insurance won’t cover Mounjaro for weight loss off-label. The FDA-approved tirzepatide product for weight management is Zepbound, the same molecule at the same doses but labeled for obesity. Patients with a BMI 30+ or 27+ with a comorbidity who don’t have diabetes need a Zepbound prescription, not Mounjaro, to use their insurance.

How Much Do You Save with the Eli Lilly Mounjaro Savings Card at Walmart?

The Mounjaro savings card from Eli Lilly drops eligible commercially insured patients to \$25 per 1-month supply at Walmart, with a maximum annual benefit currently capped at \$1,800. The card works at any retail or mail-order pharmacy including Walmart.

You can’t use the savings card if you have Medicare, Medicaid, TRICARE, VA coverage, or any other federal program. Federal anti-kickback rules prohibit manufacturer copay assistance for government-insured patients. The card also won’t help if your insurance flat-out denies coverage.

For cash-pay patients at Walmart looking at the \$1,135 sticker, the standard Mounjaro savings card doesn’t apply. Eli Lilly also operates LillyDirect, a direct-pay program for Zepbound (not Mounjaro), with single-dose vials at \$349 to \$499 per month. The Zepbound vial program isn’t available for Mounjaro.

Does Walmart Accept GoodRx Coupons for Mounjaro?

Yes. Walmart accepts GoodRx, SingleCare, RxSaver, and most prescription discount cards for Mounjaro. The discounts on branded GLP-1 drugs are modest because no generic competition exists.

In May 2026, GoodRx coupons at Walmart priced Mounjaro between \$1,029 and \$1,099 per 28-day fill, a savings of \$60 to \$110 versus the cash sticker. SingleCare prices ran within \$15 of GoodRx in most markets.

You can’t combine a discount card with insurance. If your plan covers Mounjaro for type 2 diabetes, the insurance copay almost always beats the coupon price. The coupon route makes sense for cash-pay patients without coverage.

Key Takeaway: SURPASS-2 (Frias et al. 2021 NEJM) showed tirzepatide 15 mg produced 2.30% A1c reduction and 11.2 kg weight loss versus semaglutide 1 mg.

What Does the SURPASS Trial Program Show About Mounjaro?

The SURPASS clinical trial program tested tirzepatide for type 2 diabetes across multiple head-to-head comparisons. SURPASS-2 (Frias et al. 2021 NEJM) randomized 1,879 adults with type 2 diabetes to tirzepatide 5, 10, or 15 mg or semaglutide 1 mg weekly for 40 weeks. Tirzepatide 15 mg produced a 2.30% A1c reduction versus 1.86% on semaglutide, and 11.2 kg weight loss versus 5.7 kg.

SURPASS-3 added insulin degludec as a comparator and showed tirzepatide superior on A1c and weight outcomes. SURPASS-5 tested tirzepatide added to basal insulin. SURPASS-6 compared tirzepatide to insulin lispro.

The SURMOUNT-1 trial (Jastreboff et al. 2022 NEJM), which tested tirzepatide for obesity rather than diabetes, showed 20.9% mean weight loss at 72 weeks at the highest dose. That data drove the November 2023 FDA approval of Zepbound for chronic weight management.

Why Is Mounjaro Priced Lower Than Wegovy® at Walmart?

Mounjaro at Walmart averages \$1,135 versus Wegovy at \$1,389 in 2026, a \$254 spread. Both are weekly GLP-1 injectables with strong efficacy data. The price difference reflects two factors.

First, Mounjaro is approved for diabetes only, an indication with a more established insurance coverage path and longer history of pricing pressure from PBMs. Wegovy is approved for obesity (and now CV risk reduction), indications where insurance has been more variable and manufacturers price for cash-pay patient share.

Second, Mounjaro contains 0.5 mL of solution per pen versus Wegovy’s 0.5 mL with different concentration. The wholesale acquisition costs Eli Lilly and Novo Nordisk set reflect their independent pricing strategies, not raw drug volume.

What Is Compounded Tirzepatide and How Does It Compare?

Compounded tirzepatide is the same active molecule as Mounjaro and Zepbound, prepared by FDA-registered 503A or 503B compounding pharmacies and sold through telehealth platforms for \$249 to \$449 per month in 2026. It’s not the branded Mounjaro pen; the formulation may include B12 or other adjuncts depending on the prescriber.

Compounded tirzepatide became widely available during the FDA-declared tirzepatide shortage that ended in October 2024. With the shortage resolved, 503A compounding remains permitted when a prescriber determines a patient needs a personalized formulation. The 503A regulatory pathway is narrower than during shortage status.

Telehealth platforms like TrimRx run a free assessment quiz in about five minutes and produce a personalized treatment plan. For cash-pay patients comparing the \$1,135 Walmart sticker to a \$349 compounded option, the difference is roughly 69%.

Bottom line: Compounded tirzepatide through telehealth platforms costs \$249 to \$449 per month, a 70%+ reduction versus Walmart’s cash price.

FAQ

Is Mounjaro the Same as Zepbound?

Yes and no. Both are tirzepatide, the same active molecule made by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes and Zepbound is FDA-approved for chronic weight management. The doses available are the same (2.5 through 15 mg) but the labels and pricing differ slightly.

Can I Get Mounjaro at Walmart for Weight Loss?

Only if your prescriber writes the prescription with a type 2 diabetes diagnosis. Walmart’s pharmacy fills based on the prescription as written. If the indication is obesity or weight management, the prescriber needs to write for Zepbound instead. Insurance won’t cover Mounjaro for off-label weight loss.

Does Walmart’s \$4 Generic List Include Mounjaro?

No. Walmart’s \$4 generic program covers off-patent generics. Mounjaro is brand-name and patent-protected through 2036 in the US. It won’t appear on any low-cost generic list until tirzepatide generics enter the market.

What’s the Cheapest Way to Get Tirzepatide at Walmart?

For most cash-pay patients in 2026, compounded tirzepatide through a telehealth platform at \$249 to \$449 per month is the cheapest legitimate route. The Eli Lilly LillyDirect program for Zepbound vials (\$349 to \$499) is the cheapest brand option, but it’s only for Zepbound, not Mounjaro.

Will Walmart Lower Mounjaro Prices in the Next Year?

Probably not significantly. Eli Lilly’s tirzepatide patent runs through 2036 in the US. Generic competition is years away. The bigger near-term cost levers are commercial insurance expansion and Eli Lilly’s LillyDirect program for Zepbound.

Does the SURPASS-6 Trial Support Cardiovascular Benefits for Mounjaro?

SURPASS-CVOT, the dedicated cardiovascular outcomes trial for tirzepatide, is ongoing as of 2026 with results expected later in the decade. The data so far (SURPASS-2 through SURPASS-6) shows strong A1c and weight outcomes but the formal MACE reduction hasn’t been confirmed in a powered CV outcomes trial. SELECT (for semaglutide) is the only weekly GLP-1 with proven MACE reduction.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.